These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12430239)

  • 1. [Diabetic nephropathy].
    Haneda M
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():260-9. PubMed ID: 12430239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment recommendations for various stages in diabetic nephropathy].
    Takane H; Suzuki H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():379-83. PubMed ID: 15999738
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence based treatment of diabetic nephropathy].
    Sugimoto T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():294-300. PubMed ID: 12430244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis of and therapy for patients with diabetic nephropathy].
    Makino H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):471-6. PubMed ID: 15052805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetic nephropathy].
    Koya D; Kashiwagi A
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():625-9. PubMed ID: 15779451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in diagnosis of and therapy for diabetic complication--diabetic nephropathies].
    Haneda M
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):773-8. PubMed ID: 19472530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 8. Irbesartan slows the development of diabetic nephropathy by up to 70% in hypertensive diabetic patients.
    Cardiovasc J S Afr; 2001; 12(4):242-3. PubMed ID: 11766619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetic patient with hypertension takes A-I I blocker. Less likely dialysis].
    MMW Fortschr Med; 2002 Feb; 144(8):52. PubMed ID: 11910830
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
    Eguchi K; Kario K; Shimada K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():679-84. PubMed ID: 12387069
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dangerous deficits in management of hypertensive diabetic patients. A kidney check is far from standard procedure].
    MMW Fortschr Med; 2003 Apr; 145(17):55. PubMed ID: 12808810
    [No Abstract]   [Full Text] [Related]  

  • 13. [A threat to cardiovascular risk patients. "Activated renin-angiotensin system promotes end organ damage" (interview by Waldtraud Paukstadt)].
    Schunkert H
    MMW Fortschr Med; 2004 Jun; 146(23):60. PubMed ID: 15373137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes and hypertension].
    Sayk F; Iwen KA; Lehnert H
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2296-301. PubMed ID: 19876807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the impact of PRIME on real-life diabetic nephropathy?
    Ruilope LM
    Int J Clin Pract; 2004 Mar; 58(3):268-76. PubMed ID: 15117095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What blood-pressure level provides greatest renoprotection in patients with diabetic nephropathy and hypertension?
    Ruggenenti P; Remuzzi G
    Nat Clin Pract Nephrol; 2006 May; 2(5):250-1. PubMed ID: 16932436
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
    Parving HH; Lehnert H; Bröchner-Mortensen J; Gomis R; Andersen S; Arner P;
    N Engl J Med; 2001 Sep; 345(12):870-8. PubMed ID: 11565519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early diagnosis and therapy of diabetic nephropathy].
    Shigeta Y
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):464-7. PubMed ID: 8691016
    [No Abstract]   [Full Text] [Related]  

  • 20. Irbesartan prevents the progression of kidney disease or death in patients with type 2 diabetes and high blood pressure.
    Cardiovasc J S Afr; 2001; 12(4):240-1. PubMed ID: 11766617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.